BASEL, Switzerland - Syngenta Crop Protection and Ginkgo Bioworks announced a partnership aimed at expediting the development and commercialization of a new biological solution for agriculture. The collaboration, announced today, will focus on optimizing the production of a specific secondary metabolite identified by Syngenta as a key component in its biologicals pipeline.
The partnership leverages Ginkgo's expertise in microbial strain development and its Ag Biologicals capabilities to meet Syngenta's productivity targets for the metabolite. By applying machine learning and data analysis, Ginkgo aims to develop a robust microbial strain capable of cost-effective, large-scale production, which is crucial for the timely release of Syngenta's product.
Camilla Corsi, Global Head of Research at Syngenta Crop Protection, highlighted the growing importance of biologicals in sustainable agriculture and expressed confidence in Ginkgo's capabilities to meet their productivity goals. Magalie Guilhabert, Head of Ag Biologicals at Ginkgo Bioworks, also emphasized the expansion of their successful relationship with Syngenta and the commitment to overcoming challenges in the ag biologicals sector.
The announcement follows previous collaborations between the two companies on next-generation seed technologies. This new venture is expected to contribute to the broader efforts of providing sustainable agricultural solutions to farmers worldwide.
Syngenta, headquartered in Basel, Switzerland, is known for its innovative crop protection solutions and services, while Boston-based Ginkgo Bioworks specializes in cell programming and biosecurity across various industries.
The information in this article is based on a press release.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.